Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients, with patients who lacked genetically matched donors recording the most significant gains.
Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients, with patients who lacked genetically matched donors recording the most significant gains.